KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 103 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $18,798 | -11.4% | 1,952 | -17.2% | 0.00% | – |
Q2 2023 | $21,213 | +14.5% | 2,357 | 0.0% | 0.00% | – |
Q1 2023 | $18,526 | +16.3% | 2,357 | 0.0% | 0.00% | – |
Q4 2022 | $15,933 | -53.1% | 2,357 | 0.0% | 0.00% | – |
Q3 2022 | $34,000 | +70.0% | 2,357 | +14.8% | 0.00% | – |
Q2 2022 | $20,000 | -50.0% | 2,053 | -26.0% | 0.00% | – |
Q1 2022 | $40,000 | +8.1% | 2,773 | 0.0% | 0.00% | – |
Q4 2021 | $37,000 | -11.9% | 2,773 | +13.1% | 0.00% | – |
Q3 2021 | $42,000 | -28.8% | 2,452 | 0.0% | 0.00% | – |
Q2 2021 | $59,000 | +37.2% | 2,452 | +47.2% | 0.00% | – |
Q1 2021 | $43,000 | +72.0% | 1,666 | +26.4% | 0.00% | – |
Q4 2020 | $25,000 | +47.1% | 1,318 | 0.0% | 0.00% | – |
Q3 2020 | $17,000 | -19.0% | 1,318 | -24.1% | 0.00% | – |
Q2 2020 | $21,000 | +31.2% | 1,736 | -17.3% | 0.00% | – |
Q1 2020 | $16,000 | -60.0% | 2,099 | -13.3% | 0.00% | – |
Q4 2019 | $40,000 | +73.9% | 2,422 | +24.6% | 0.00% | – |
Q3 2019 | $23,000 | -46.5% | 1,944 | 0.0% | 0.00% | – |
Q2 2019 | $43,000 | – | 1,944 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 1,719,576 | $38,088,000 | 25.57% |
VHCP Management III, LLC | 637,884 | $14,129,000 | 6.60% |
Vivo Capital, LLC | 1,359,149 | $30,105,000 | 2.82% |
INTERWEST VENTURE MANAGEMENT CO | 388,766 | $8,611,000 | 2.78% |
VHCP Management II, LLC | 376,889 | $8,348,000 | 2.63% |
Samsara BioCapital, LLC | 118,500 | $2,625,000 | 1.73% |
ACUTA CAPITAL PARTNERS, LLC | 213,000 | $4,718,000 | 1.68% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 187,599 | $4,165,000 | 1.54% |
Ghost Tree Capital, LLC | 300,000 | $6,645,000 | 1.38% |
Eventide Asset Management | 1,500,000 | $33,225,000 | 1.01% |